BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30340599)

  • 1. Defining the minimally clinically important difference of the SF-36 physical function subscale for paediatric CFS/ME: triangulation using three different methods.
    Brigden A; Parslow RM; Gaunt D; Collin SM; Jones A; Crawley E
    Health Qual Life Outcomes; 2018 Oct; 16(1):202. PubMed ID: 30340599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the factors associated with meaningful improvement on the SF-36-PFS and exploring the appropriateness of this measure for young people with ME/CFS accessing an NHS specialist service: a prospective cohort study.
    Gaunt D; Brigden A; Metcalfe C; Loades M; Crawley E
    BMJ Open; 2023 Aug; 13(8):e069110. PubMed ID: 37620254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important factors to consider when treating children with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): perspectives of health professionals from specialist services.
    Parslow RM; Shaw A; Haywood KL; Crawley E
    BMC Pediatr; 2017 Feb; 17(1):43. PubMed ID: 28143516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a conceptual framework to underpin a health-related quality of life outcome measure in paediatric chronic fatigue syndrome/myalgic encephalopathy (CFS/ME): prioritisation through card ranking.
    Parslow RM; Anderson N; Byrne D; Haywood KL; Shaw A; Crawley E
    Qual Life Res; 2020 May; 29(5):1169-1181. PubMed ID: 31907870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What matters to children with CFS/ME? A conceptual model as the first stage in developing a PROM.
    Parslow R; Patel A; Beasant L; Haywood K; Johnson D; Crawley E
    Arch Dis Child; 2015 Dec; 100(12):1141-7. PubMed ID: 26453575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graded exercise therapy compared to activity management for paediatric chronic fatigue syndrome/myalgic encephalomyelitis: pragmatic randomized controlled trial.
    Gaunt DM; Brigden A; Harris SRS; Hollingworth W; Jago R; Solomon-Moore E; Beasant L; Mills N; Sinai P; Crawley E; Metcalfe C
    Eur J Pediatr; 2024 May; 183(5):2343-2351. PubMed ID: 38429546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the effectiveness and cost-effectiveness of FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to Activity Management to treat paediatric chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME): protocol for a randomised controlled trial.
    Baos S; Brigden A; Anderson E; Hollingworth W; Price S; Mills N; Beasant L; Gaunt D; Garfield K; Metcalfe C; Parslow R; Downing H; Kessler D; Macleod J; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Crawley E
    Trials; 2018 Feb; 19(1):136. PubMed ID: 29471861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Children's experiences of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review and meta-ethnography of qualitative studies.
    Parslow RM; Harris S; Broughton J; Alattas A; Crawley E; Haywood K; Shaw A
    BMJ Open; 2017 Jan; 7(1):e012633. PubMed ID: 28087544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric properties of the PROMIS
    Yang M; Keller S; Lin JS
    Qual Life Res; 2019 Dec; 28(12):3375-3384. PubMed ID: 31506915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing specialist medical care with specialist medical care plus the Lightning Process for chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME): study protocol for a randomised controlled trial (SMILE Trial).
    Crawley E; Mills N; Hollingworth W; Deans Z; Sterne JA; Donovan JL; Beasant L; Montgomery A
    Trials; 2013 Dec; 14():444. PubMed ID: 24370208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What stops children with a chronic illness accessing health care: a mixed methods study in children with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
    Webb CM; Collin SM; Deave T; Haig-Ferguson A; Spatz A; Crawley E
    BMC Health Serv Res; 2011 Nov; 11():308. PubMed ID: 22078101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of school in the management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): issues identified by adolescents and their families.
    Clery P; Linney C; Parslow R; Starbuck J; Laffan A; Leveret J; Crawley E
    Health Soc Care Community; 2022 Nov; 30(6):e5234-e5244. PubMed ID: 35996850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The financial and psychological impacts on mothers of children with chronic fatigue syndrome (CFS/ME).
    Missen A; Hollingworth W; Eaton N; Crawley E
    Child Care Health Dev; 2012 Jul; 38(4):505-12. PubMed ID: 21880054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Are the Minimum Clinically Important Differences in SF-36 Scores in Patients with Orthopaedic Oncologic Conditions?
    Ogura K; Yakoub MA; Christ AB; Fujiwara T; Nikolic Z; Boland PJ; Healey JH
    Clin Orthop Relat Res; 2020 Sep; 478(9):2148-2158. PubMed ID: 32568896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing severity of illness and outcomes of treatment in children with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME): a systematic review of patient-reported outcome measures (PROMs).
    Haywood KL; Collin SM; Crawley E
    Child Care Health Dev; 2014 Nov; 40(6):806-24. PubMed ID: 24661148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "it's a medical condition … you need to support as much as possible": a qualitative analysis of teachers' experiences of chronic fatigue syndrome / myalgic encephalomyelitis (CFS/ME).
    Brigden A; Shaw A; Crawley E
    BMC Pediatr; 2021 Jan; 21(1):6. PubMed ID: 33397331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme.
    O'Dowd H; Gladwell P; Rogers CA; Hollinghurst S; Gregory A
    Health Technol Assess; 2006 Oct; 10(37):iii-iv, ix-x, 1-121. PubMed ID: 17014748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Murdock KW; Wang XS; Shi Q; Cleeland CS; Fagundes CP; Vernon SD
    Qual Life Res; 2017 Apr; 26(4):913-921. PubMed ID: 27600520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruiting Adolescents With Chronic Fatigue Syndrome/Myalgic Encephalomyelitis to Internet-Delivered Therapy: Internal Pilot Within a Randomized Controlled Trial.
    Anderson E; Parslow R; Hollingworth W; Mills N; Beasant L; Gaunt D; Metcalfe C; Kessler D; Macleod J; Pywell S; Pitts K; Price S; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Crawley E
    J Med Internet Res; 2020 Aug; 22(8):e17768. PubMed ID: 32784188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcome in adults with chronic fatigue syndrome: a prospective study in England based on the CFS/ME National Outcomes Database.
    Crawley E; Collin SM; White PD; Rimes K; Sterne JA; May MT;
    QJM; 2013 Jun; 106(6):555-65. PubMed ID: 23538643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.